Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 81 to 90 of 302 resources
-
Reduction in Liver Transplant Wait-Listing in the Era of Direct-Acting Antiviral Therapy
This paper analyses trends in liver transplant wait-listing to explore the potential impact of direct acting antiviral (DAA) treatments for hepatitis C on wait-listing registration. The authors conclude that the rate of liver transplant wait-listing for hepatitis C complicated by decompensated cirrhosis has decreased by over 30% in the era of DAA therapy. Further reductions in wait-listing are anticipated with increased testing, linkage to care, and access to DAA therapy.Rest of World Reports & Research PDF -
Good practice case study: Ipswich NHS Trust prison in-reach
In August 2015, Ipswich NHS Trust launched an in-reach treatment service in four prisons, seeking to increase the number of inmates receiving treatment for hepatitis C. Despite a number of challenges, clear pathways have been established for engaging patients into treatment, which has resulted in a substantial increase in the number of prisoners being treated for the virus.UK, England, East of England Case study PDF -
Hepatitis B and C testing activities, needs, and priorities in the EU/EEA
Hepatitis B and C virus infections are associated with a considerable burden of disease in Europe. The European Centre for Disease Prevention and Control undertook a survey to assess needs and priorities prior to developing guidance on testing and screening for hepatitis B and C in the EU/EEA, and to update the existing evidence on the burden of HBV/HCV morbidity and mortality across EU/EEA Member States.Rest of World Reports & Research PDF -
NICE Quality Standard on Liver Disease
This NICE quality standard covers identifying, assessing and managing chronic liver disease in children, young people and adults, and cirrhosis in young people and adults. It describes high-quality care in priority areas for improvement.UK, England Jun 2017 Other, Strategy & Planning PDF -
Annual statement of progress: Liver Disease Delivery Plan
This report provides an update on the Welsh Government's Liver Disease Delivery Plan, which was launched in 2015. It reports Wales is the only country in the UK to have no restrictions on access to new hepatitis C treatments, with the next challenge being to find and test the undiagnosed.UK, Wales Jun 2017 Reports & Research PDF -
Summary report: Hepatitis C good practice roadshow, Cambridge
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Cambridge on 9th May 2017. The roadshow was aimed at sharing good practice around hepatitis C and instigating local action to address the virus. The report includes summaries of the talks and workshops held on the day, as well as attendees' pledges for taking further action on hepatitis C.UK, England, East of England Reports & Research PDF -
Hepatitis C scare stories: true or false
Produced by Sheffield Teaching Hospitals NHS Foundation Trust, this resource is a series of posters which address common perceptions of hepatitis C, dispelling myths and providing facts about the virus.UK Other, Tools & Templates PDF -
HCV Action and PHE hepatitis C roadshow in Cambridge: Presentations
On 9th May 2017, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Cambridge. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Cambridge and the wider east of England region.UK, England, East of England Other, Strategy & Planning PDF -
Global Hepatitis Report 2017
This WHO Global hepatitis report describes the global and regional estimates on viral hepatitis in 2015, setting the baseline for tracking progress in implementing the new global strategy.Rest of World Apr 2017 Reports & Research PDF -
Needle Exchange Surveillance Initiative: 2008-9 to 2015-16
The Needle Exchange Surveillance Initiative measures and monitorings the prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs in Scotland. This report presents the results, at the NHS board level, for the data collection period from February 2015 until March 2016. It also presents the findings of the NESI survey, at Scotland-wide level, from 2008-09 until the most recent survey, 2015-16.UK, Scotland Mar 2017 Reports & Research PDF